Annabel Samimy Score: 34
Analyst at
Stifel Nicolaus
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+48.9%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
53%
16 W / 14 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
68%
13 W / 6 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
11%
2 W / 17 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
5%
1 W / 18 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
58%
14 W / 10 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
54%
15 W / 13 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
50%
1 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 |
EyePoint Pharmaceuticals Inc
EYPT
|
BUY |
$40.00
Est. +189%
|
$13.85 | $14.20 |
Pending
|
$12.66
-8.6%
|
| Jul 08, 2026 |
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
|
BUY |
$332.00
Est. +4%
|
$319.43 | $326.63 |
Precision Hit (±3%)
|
$304.26
-4.7%
|
| May 08, 2026 |
Trevi Therapeutics Inc
TRVI
|
BUY |
$30.00
Est. +114%
|
$14.05 | $20.15 |
Pending
|
$17.36
+23.6%
|
| Mar 11, 2026 |
Kamada Ltd
KMDA
|
BUY |
$11.00
Est. +29%
|
$8.55 | $9.03 |
Pending
|
$7.01
-18.0%
|
| Mar 04, 2026 |
Oculis Holding AG
OCS
|
BUY |
$50.00
Est. +80%
|
$27.72 | $34.13 |
Pending
|
$11.43
-58.8%
|
| Feb 26, 2026 |
Phathom Pharmaceuticals Inc
PHAT
|
BUY |
$28.00
Est. +106%
|
$13.62 | $14.39 |
Pending
|
$11.70
-14.1%
|
| Jan 13, 2026 |
Evolus Inc
EOLS
|
BUY |
$17.00
Est. +195%
|
$5.77 | $7.32 |
Pending
|
$5.89
+2.1%
|
| Dec 19, 2025 |
Supernus Pharmaceuticals Inc
SUPN
|
BUY |
$55.00
Est. +12%
|
$49.28 | $59.68 |
Target Met
|
$46.94
-4.7%
|
| Dec 19, 2025 |
Oculis Holding AG
OCS
|
BUY |
$40.00
Est. +91%
|
$20.98 | $34.13 |
Pending
|
$11.43
-45.5%
|
| Dec 19, 2025 |
MBX Biosciences, Inc. Common Stock
MBX
|
BUY |
$50.00
Est. +74%
|
$28.67 | $66.55 |
Target Met
|
$58.30
+103.3%
|
| Dec 02, 2025 |
Structure Therapeutics Inc - ADR
GPCR
|
BUY |
$50.00
Est. +48%
|
$33.89 | $94.90 |
Target Met
|
$50.41
+48.7%
|
| Nov 06, 2025 |
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
|
BUY |
$220.00
Est. +6%
|
$208.22 | $326.63 |
Target Met
|
$304.26
+46.1%
|
| Sep 24, 2025 |
Palvella Therapeutics, Inc.
PVLA
|
BUY |
$80.00
Est. +34%
|
$59.87 | $158.20 |
Target Met
|
$142.18
+137.5%
|
| Mar 25, 2025 |
Palvella Therapeutics, Inc.
PVLA
|
BUY |
$45.00
Est. +65%
|
$27.27 | $151.18 |
Target Met
|
$142.18
+421.4%
|
| Nov 13, 2024 |
Kamada Ltd
KMDA
|
BUY |
$20.00
Est. +232%
|
$6.03 | $9.15 |
Miss
|
$7.01
+16.3%
|
| Sep 20, 2024 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$84.00
Est. +165%
|
$31.68 | $35.72 |
Miss
|
$41.03
+29.5%
|
| Sep 11, 2024 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$230.00
Est. +119%
|
$105.22 | $148.14 |
Miss
|
$250.41
+138.0%
|
| Jun 24, 2024 |
Rani Therapeutics Holdings Inc - Ordinary Shares Class A
RANI
|
BUY |
$10.00
Est. +143%
|
$4.11 | $4.19 |
Miss
|
$0.90
-78.2%
|
| Jun 24, 2024 |
Regenxbio Inc
RGNX
|
BUY |
$40.00
Est. +213%
|
$12.79 | $15.36 |
Miss
|
$10.20
-20.3%
|
| Jun 12, 2024 |
Cara Therapeutics Inc
CARA
|
BUY |
$1.00
Est. +47%
|
$0.68 | $25.92 |
Target Met
|
$5.32
+682.4%
|
| May 28, 2024 |
Calliditas Therapeutics AB - ADR
CALT
|
BUY |
$40.00
Est. +5%
|
$38.06 | $43.00 |
Target Met
|
$40.00
+5.1%
|
| May 02, 2024 |
Phathom Pharmaceuticals Inc
PHAT
|
BUY |
$24.00
Est. +146%
|
$9.76 | $19.71 |
Miss
|
$11.70
+19.9%
|
| Apr 08, 2024 |
Supernus Pharmaceuticals Inc
SUPN
|
BUY |
$38.00
Est. +18%
|
$32.27 | $40.28 |
Target Met
|
$46.94
+45.5%
|
| Jun 02, 2023 |
FibroGen Inc
FGEN
|
BUY |
$28.00
Est. +62%
|
$17.32 | $486.75 |
Target Met
|
$9.07
-47.6%
|
| Apr 16, 2023 |
Prometheus Biosciences Inc
RXDX
|
BUY |
$200.00
Est. +75%
|
$114.01 | $199.96 |
Bullseye Hit (±1%)
|
$199.92
+75.4%
|
| Aug 03, 2022 |
Horizon Therapeutics Plc
HZNP
|
BUY |
$138.00
Est. +112%
|
$64.95 | - | - |
$116.30
+79.1%
|
| Jun 30, 2022 |
Elicio Therapeutics Inc.
ELTX
|
SELL |
$1.50
Est. +12%
|
$1.71 | - | - |
$3.12
-82.5%
|
| Jun 30, 2022 |
Angion Biomedica Corp
ANGN
|
SELL |
$1.50
Est. +91%
|
$17.10 | $1.00 (Low) |
Target Met
|
$1.00
+94.2%
|
| Jun 23, 2022 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$60.00
Est. +35%
|
$44.53 | - | - |
$41.03
-7.9%
|
| Jan 14, 2022 |
Jazz Pharmaceuticals plc
JAZZ
|
BUY |
$210.00
Est. +46%
|
$144.30 | - | - |
$250.41
+73.5%
|
EyePoint Pharmaceuticals Inc
EYPT
Jul 15, 2026
Signal & Target
BUY
$40.00
Start Price
$13.85
Best Price (1Y)
$14.20
Current Price
$12.66
Return
-8.6%
Signal & Target
BUY
$332.00
Start Price
$319.43
Best Price (1Y)
$326.63
Current Price
$304.26
Return
-4.7%
Trevi Therapeutics Inc
TRVI
May 08, 2026
Signal & Target
BUY
$30.00
Start Price
$14.05
Best Price (1Y)
$20.15
Current Price
$17.36
Return
+23.6%
Kamada Ltd
KMDA
Mar 11, 2026
Signal & Target
BUY
$11.00
Start Price
$8.55
Best Price (1Y)
$9.03
Current Price
$7.01
Return
-18.0%
Oculis Holding AG
OCS
Mar 04, 2026
Signal & Target
BUY
$50.00
Start Price
$27.72
Best Price (1Y)
$34.13
Current Price
$11.43
Return
-58.8%
Phathom Pharmaceuticals Inc
PHAT
Feb 26, 2026
Signal & Target
BUY
$28.00
Start Price
$13.62
Best Price (1Y)
$14.39
Current Price
$11.70
Return
-14.1%
Evolus Inc
EOLS
Jan 13, 2026
Signal & Target
BUY
$17.00
Start Price
$5.77
Best Price (1Y)
$7.32
Current Price
$5.89
Return
+2.1%
Supernus Pharmaceuticals Inc
SUPN
Dec 19, 2025
Signal & Target
BUY
$55.00
Start Price
$49.28
Best Price (1Y)
$59.68
Current Price
$46.94
Return
-4.7%
Oculis Holding AG
OCS
Dec 19, 2025
Signal & Target
BUY
$40.00
Start Price
$20.98
Best Price (1Y)
$34.13
Current Price
$11.43
Return
-45.5%
MBX Biosciences, Inc. Common Stock
MBX
Dec 19, 2025
Signal & Target
BUY
$50.00
Start Price
$28.67
Best Price (1Y)
$66.55
Current Price
$58.30
Return
+103.3%
Structure Therapeutics Inc - ADR
GPCR
Dec 02, 2025
Signal & Target
BUY
$50.00
Start Price
$33.89
Best Price (1Y)
$94.90
Current Price
$50.41
Return
+48.7%
Signal & Target
BUY
$220.00
Start Price
$208.22
Best Price (1Y)
$326.63
Current Price
$304.26
Return
+46.1%
Palvella Therapeutics, Inc.
PVLA
Sep 24, 2025
Signal & Target
BUY
$80.00
Start Price
$59.87
Best Price (1Y)
$158.20
Current Price
$142.18
Return
+137.5%
Palvella Therapeutics, Inc.
PVLA
Mar 25, 2025
Signal & Target
BUY
$45.00
Start Price
$27.27
Best Price (1Y)
$151.18
Current Price
$142.18
Return
+421.4%
Kamada Ltd
KMDA
Nov 13, 2024
Signal & Target
BUY
$20.00
Start Price
$6.03
Best Price (1Y)
$9.15
Current Price
$7.01
Return
+16.3%
Apellis Pharmaceuticals Inc
APLS
Sep 20, 2024
Signal & Target
BUY
$84.00
Start Price
$31.68
Best Price (1Y)
$35.72
Current Price
$41.03
Return
+29.5%
Jazz Pharmaceuticals plc
JAZZ
Sep 11, 2024
Signal & Target
BUY
$230.00
Start Price
$105.22
Best Price (1Y)
$148.14
Current Price
$250.41
Return
+138.0%
Signal & Target
BUY
$10.00
Start Price
$4.11
Best Price (1Y)
$4.19
Current Price
$0.90
Return
-78.2%
Regenxbio Inc
RGNX
Jun 24, 2024
Signal & Target
BUY
$40.00
Start Price
$12.79
Best Price (1Y)
$15.36
Current Price
$10.20
Return
-20.3%
Cara Therapeutics Inc
CARA
Jun 12, 2024
Signal & Target
BUY
$1.00
Start Price
$0.68
Best Price (1Y)
$25.92
Current Price
$5.32
Return
+682.4%
Calliditas Therapeutics AB - ADR
CALT
May 28, 2024
Signal & Target
BUY
$40.00
Start Price
$38.06
Best Price (1Y)
$43.00
Current Price
$40.00
Return
+5.1%
Phathom Pharmaceuticals Inc
PHAT
May 02, 2024
Signal & Target
BUY
$24.00
Start Price
$9.76
Best Price (1Y)
$19.71
Current Price
$11.70
Return
+19.9%
Supernus Pharmaceuticals Inc
SUPN
Apr 08, 2024
Signal & Target
BUY
$38.00
Start Price
$32.27
Best Price (1Y)
$40.28
Current Price
$46.94
Return
+45.5%
FibroGen Inc
FGEN
Jun 02, 2023
Signal & Target
BUY
$28.00
Start Price
$17.32
Best Price (1Y)
$486.75
Current Price
$9.07
Return
-47.6%
Prometheus Biosciences Inc
RXDX
Apr 16, 2023
Signal & Target
BUY
$200.00
Start Price
$114.01
Best Price (1Y)
$199.96
Current Price
$199.92
Return
+75.4%
Horizon Therapeutics Plc
HZNP
Aug 03, 2022
Signal & Target
BUY
$138.00
Start Price
$64.95
Best Price (1Y)
-
Current Price
$116.30
Return
+79.1%
Elicio Therapeutics Inc.
ELTX
Jun 30, 2022
Signal & Target
SELL
$1.50
Start Price
$1.71
Best Price (1Y)
-
Current Price
$3.12
Return
-82.5%
Angion Biomedica Corp
ANGN
Jun 30, 2022
Signal & Target
SELL
$1.50
Start Price
$17.10
Best Price (1Y)
$1.00
Current Price
$1.00
Return
+94.2%
Apellis Pharmaceuticals Inc
APLS
Jun 23, 2022
Signal & Target
BUY
$60.00
Start Price
$44.53
Best Price (1Y)
-
Current Price
$41.03
Return
-7.9%
Jazz Pharmaceuticals plc
JAZZ
Jan 14, 2022
Signal & Target
BUY
$210.00
Start Price
$144.30
Best Price (1Y)
-
Current Price
$250.41
Return
+73.5%